Previous Studies Archive
Here is a list of studies we have completed in the past. Click in the category to learn more.
Prompt Panretinal Photocoagulation versus Intravitreal Ranibizumab with Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
- More information at:
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
- More information at:
Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity
- More information at:
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy
- More information at:
Randomized Trial of Intravitreous Aflibercept versus Intravitreous Bevacizumab + Deferred Aflibercept for Treatment of Central-Involved Diabetic Macular Edema
- More information at:
- https://clinicaltrials.gov/ct2/show/NCT03321513?term=Protocol+ac%2C+DRCR&rank=1
- http://drcrnet.jaeb.org/Studies.aspx?RecID=514
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) (iDEAL)
- More information at: https://clinicaltrials.gov/ct2/show/NCT01565148?term=ideal&cond=DME&rank=1
A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
- More information at: https://clinicaltrials.gov/ct2/show/NCT02435862?term=allegro&draw=2&rank=22
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema
- More information at: https://clinicaltrials.gov/ct2/show/NCT02348918?term=allegro&draw=2&rank=23
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) (PANORAMA)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02718326?term=panorama&recrs=d&rank=1
The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) (TIME-2b)
- More information at: https://clinicaltrials.gov/ct2/show/NCT03197870?term=aerpio&recrs=d&rank=1
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema (BOULEVARD)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02699450?term=RO6867461&rank=4
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02247479?term=chroma&rank=1
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
- More information at: https://clinicaltrials.gov/ct2/show/NCT01602120?term=Lampalizumab&rank=2
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (Nexus)
- More information at: https://clinicaltrials.gov/ct2/show/NCT01414153?term=lpath&rank=3
A Proof-of-Concept Study of RO6867461 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (AVENUE)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02484690?term=roche%2C+avenue&rank=1
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration (SEQUOIA)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02462486?term=sequoia&rank=4
Efficacy and Safety of RTH258 Versus Aflibercept (HAWK)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02307682?term=rth258&rank=2
Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD (HAWK EXT)
- More information at: https://clinicaltrials.gov/ct2/show/NCT03386474?term=Brolucizumab&rank=3
Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02914639?term=scifluor&rank=1
Candela
- The primary objectives of the study are to determine the safety of high-dose aflibercept and to determine if HD provides greater intraocular pharmacodynamic effect and/or longer duration of action compared to intravitreal aflibercept injection.
HTS1 - Glasses versus Observation for Moderate Hyperopia in Young Children
- More information at:
IXT2 - A Randomized Clinical Trial of Observation versus Occlusion Therapy for Intermittent Exotropia
- More information at:
ATS18 - Study of Binocular Computer Activities for Treatment of Amblyopia
- More information at:
C02 - Pediatric Cataract Surgery Outcomes Registry
- More information at:
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
- This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.
A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools (CLEAR)
- More information at: https://clinicaltrials.gov/ct2/show/NCT02871817?term=digisight&rank=1
Repository for Inherited Eye Diseases
- More information at: https://clinicaltrials.gov/ct2/show/NCT00378742?term=eyegene&rank=1
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
- More information at: https://clinicaltrials.gov/ct2/show/NCT00765804?term=eyegate&rank=4
